0.20Open0.20Pre Close0 Volume54 Open Interest63.00Strike Price0.00Turnover90.39%IV13.77%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.20Extrinsic Value100Contract SizeAmericanOptions Type-0.0623Delta0.0172Gamma364.15Leverage Ratio-0.0932Theta-0.0005Rho-22.69Eff Leverage0.0097Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet